Search

Filters
Types

Sign up for our free
equity research notes

Register
257 Results for ‘international biotechnology’
Embed
RIT Capital Partners – Change in fortunes on the horizon

Change in fortunes on the horizon RIT Capital Partners’ (RIT’s) private (unquoted) investments portfolio, which for the past two years has dragged on the trust’s net asset value (NAV) returns, could be the spark for a change in its fortunes over the next 12 months. Several holdings are considering initial public offerings (IPOs) that could […]

RIT Capital Partners – Change in fortunes on the horizon

Change in fortunes on the horizon RIT Capital Partners’s (RIT’s) private investments portfolio, which for the past two years has dragged on the trust’s NAV returns, could be the spark for a change in its fortunes over the next 12 months. Several holdings are considering IPOs that could present healthy premiums to the typically conservative […]

Worldwide Healthcare benefits from big pharma, medtech and emerging biotech perfomance

Worldwide Healthcare (WWH) has published its annual results for the year ended 31 March 2024, during which it provided NAV and share price total returns of 12.0% and 8.6% respectively, which compare to a return from its MSCI World Health Care benchmark of 10.9% (all in sterling terms). The difference between the performance of the […]

Biotech overweight hurts Worldwide Healthcare
Edinburgh Worldwide – “The opportunity is as exciting as ever”

Edinburgh Worldwide Investment companies | Annual Overview | 13 February 2024 “The opportunity is as exciting as ever” As the rate of inflation continues its descent (barring a small bounce in the UK in December 2023) interest rates look likely to fall. Growth stocks have been recovering and Edinburgh Worldwide (EWI), the most growth-focused of […]

Edinburgh Worldwide – “The opportunity is as exciting as ever”

Edinburgh Worldwide Investment companies | Annual Overview | 13 February 2024 “The opportunity is as exciting as ever” As the rate of inflation continues its descent (barring a small bounce in the UK in December 2023) interest rates look likely to fall. Growth stocks have been recovering and Edinburgh Worldwide (EWI), the most growth-focused of […]

Edinburgh Worldwide – “The opportunity is as exciting as ever”

Edinburgh Worldwide Investment companies | Annual Overview | 13 February 2024 “The opportunity is as exciting as ever” As the rate of inflation continues to fall (barring a small bounce in the UK in December 2023) interest rates look likely to fall. Growth stocks, which tend to suffer disproportionately when interest rates rise, have been […]

QuotedData’s Investment Companies Roundup – January 2024

January 2024 Monthly | Investment companies  Kindly sponsored by abrdn  Winners and losers in December 2023 December saw a continuation of November’s market rally, with the MSCI All Countries World Index up 4.1%. However, the excitement did show signs of faltering towards the end of the month, as investors had to weigh the actual likelihood […]

QuotedData’s Investment Companies Annual Review – 2023

Review 2023 Annual roundup | Investment companies | January 2024 Over the worst, and the bulls are loose While there were plenty of financial headlines over 2023, inflation was still the main influence on markets. Rates of inflation are well below their 2022 peaks, but it was only towards the end of October 2023 that […]

QuotedData’s Economic and Political Monthly Roundup December 2023

Economic and Political Roundup Investment companies | Monthly | December 2023 November saw a deepening of the world’s geopolitical woes, with intensifying conflict in the Middle East and continued belligerence in Ukraine. Despite the hostilities, the market mood was optimistic thanks to collapsing US Treasury yields, driving government bonds to their best monthly return since […]

European Opportunities Trust – ‘Special’ growth companies

European Opportunities Trust Investment companies | Initiation | 1 November 2023 ‘Special’ growth companies With its strong focus on growth, European Opportunities Trust (EOT) has faced significant headwinds during the last couple of years as, in the face of higher inflation and interest rates, investors have favoured more value and defensive exposures over growth stocks. Inflation […]